News

Research Paper Published - A One Man Army- TrueNat Testing for the Identification of COVID-19 in Firozabad, Uttar Pradesh, India

Journal of Clinical and Diagnostic Research ; 16(5):DC01-DC05, 2022., July 05, 2022

The Coronavirus Disease 2019 (COVID-19) pandemic has affected the entire world. The need of timely detection of the virus has been of prime importance and the efforts to develop sensitive, specific, rapid, portable and cost effective diagnostic methods promoted the indigenous development of TrueNat testing for viral load in COVID-19 detection which had been previously designed for detection of Tuberculosis and other infectious organisms.

TB can now be diagnosed in two to 72 hours with the latest tests

Express News Service | Chandigarh |, March 26, 2022

A two-day CME-cum-workshop on tuberculosis started on Saturday, as part of World TB week at the Department of Medical Microbiology, PGI Chandigarh. Dr Sunil Sethi, Professor and organising secretary of TBCON 2022, said that over 300 delegates from all over India will be attending this event.

TB diagnosis: Strengthening first line of defence a must

Prathiba Raju, ET Health World, March 24, 2022

The door-to-door tuberculosis screening campaign with Truenat machines .....

Union govt deploys Molbio Diagnostics’ to conduct door-to-door TB screening campaign

ET Health World, March 17, 2022

Molbio Diagnostics’ indigenously developed Truenat platform a point-of-care portable, battery-operated, IoT-enabled, Real Time PCR platform with a sample to result time of less than one hour to be used in the door-to-door campaign by health workers to test those found to have symptoms of TB

In Quest for Building Better Healthcare – Dr Chandrashekhar Nair

Arati Halbe, Research Matters, March 02, 2022

In an exclusive interview with Research Matters, Dr Chandrashekhar Nair, awardee of the Infosys Prize for Engineering and Computer Science 2021, shared the motivation, challenges and breakthroughs during the making of Truenat®, a portable, battery-operated PCR testing platform. 

RT-PCR test kit for Omicron ready, will approach ICMR if need arises, says TrueNat maker

The Print, December 18, 2021

Molbio Diagnostics director & chief technical officer Chandrasekhar Nair, awarded Infosys Prize 2021 this month, says they are waiting to see 'impact' of variant on public health.

Importance of Point-of-Care Testing in India

The Health Site, December 15, 2021

The ongoing COVID-19 pandemic has exposed the huge gaps in India's health care system and the need for novel point-of-care solutions

Infosys Prize 2021 highlights best of science, research in India

Team Lounge, Livemint, December 03, 2021

Chandrasekhar Nair, chief technology officer of Molbio Diagnostics in Bengaluru, was awarded the prize in engineering and computer science for the development and large-scale deployment of TrueNat, a new point-of-care testing platform for PCR-based medical diagnostics.

Three from Bengaluru bag Infosys Prize 2021

The Hindu, December 03, 2021

Chandrasekhar Nair, CTO of Molbio Diagnostics, for his development and large-scale deployment of TrueNat, a new point-of-care testing platform for PCR-based medical diagnostics.

Truenat is today fulfilling goal of being a multi-disease platform: Chandrasekhar Nair, Molbio Diagnostics

Shardul Nautiyal, Financial Express Health care, October 26, 2021

Truenat was validated extensively by ICMR and FIND for Indian and WHO approvals for sensitive and rapid detection of MDR-TB